Oura's recent public S-1 filing, disclosing $1.21 billion in nine-month revenue through June 2026 (up 74% year-over-year) alongside 5 million paid members and improving profitability, anchors trader sentiment around implied closing market caps near or above $15–20 billion. This momentum builds on fiscal 2025 revenue more than doubling to $908 million and 2026 targets approaching $2 billion, reflecting a premium to the prior $11 billion Series E valuation amid plans for a September Nasdaq debut raising up to $3 billion. High-margin recurring membership revenue (near 89% gross) and longitudinal health data provide differentiation versus emerging competitors like Ultrahuman and Samsung, though IPO pricing, secondary share sales, and broader market reception introduce uncertainty across the closely matched leading brackets.
สรุปจาก AI ทดลองที่อ้างอิงข้อมูลจาก Polymarket ไม่ใช่คำแนะนำในการเทรดและไม่มีผลต่อการตัดสินตลาดนี้ · อัปเดตแล้ว$20B+ 31%
$15B–$17.5B 27%
$17.5B–$20B 21%
$12.5B–$15B 21%
$444,165 ปริมาณ
$444,165 ปริมาณ
<$7.5B
<1%
$7.5B–$10B
<1%
$10B–$12.5B
3%
$12.5B–$15B
21%
$15B–$17.5B
27%
$17.5B–$20B
21%
$20B+
31%
No IPO before January 2027
<1%
$20B+ 31%
$15B–$17.5B 27%
$17.5B–$20B 21%
$12.5B–$15B 21%
$444,165 ปริมาณ
$444,165 ปริมาณ
<$7.5B
<1%
$7.5B–$10B
<1%
$10B–$12.5B
3%
$12.5B–$15B
21%
$15B–$17.5B
27%
$17.5B–$20B
21%
$20B+
31%
No IPO before January 2027
<1%
If no IPO occurs by December 31, 2026, 11:59 PM ET, the market will resolve to "No IPO before January 2027".
Market capitalization expresses the monetary value of a company’s outstanding shares, stated in its pricing currency. It is calculated as the number of shares outstanding multiplied by the closing share price on the first trading day.
If the relevant value falls exactly between two brackets, then this market will resolve to the higher range bracket.
Resolution will be based on the primary exchange’s official listing page. In the event that the relevant figure is not displayed, another reliable source will be used.
In the event of an interruption in the course of the normal trading session on Oura’s first day of trading (e.g., a circuit breaker or half-day), the market will resolve according to the official closing price of the abbreviated session. If no such official closing price is published, the market will resolve according to the next trading day on which an official closing price is published, treating that as the first day of trading for purposes of this market.
ตลาดเปิดเมื่อ: May 26, 2026, 12:28 PM ET
ผู้ตัดสินผล
0x69c47De9D...If no IPO occurs by December 31, 2026, 11:59 PM ET, the market will resolve to "No IPO before January 2027".
Market capitalization expresses the monetary value of a company’s outstanding shares, stated in its pricing currency. It is calculated as the number of shares outstanding multiplied by the closing share price on the first trading day.
If the relevant value falls exactly between two brackets, then this market will resolve to the higher range bracket.
Resolution will be based on the primary exchange’s official listing page. In the event that the relevant figure is not displayed, another reliable source will be used.
In the event of an interruption in the course of the normal trading session on Oura’s first day of trading (e.g., a circuit breaker or half-day), the market will resolve according to the official closing price of the abbreviated session. If no such official closing price is published, the market will resolve according to the next trading day on which an official closing price is published, treating that as the first day of trading for purposes of this market.
ผู้ตัดสินผล
0x69c47De9D...Oura's recent public S-1 filing, disclosing $1.21 billion in nine-month revenue through June 2026 (up 74% year-over-year) alongside 5 million paid members and improving profitability, anchors trader sentiment around implied closing market caps near or above $15–20 billion. This momentum builds on fiscal 2025 revenue more than doubling to $908 million and 2026 targets approaching $2 billion, reflecting a premium to the prior $11 billion Series E valuation amid plans for a September Nasdaq debut raising up to $3 billion. High-margin recurring membership revenue (near 89% gross) and longitudinal health data provide differentiation versus emerging competitors like Ultrahuman and Samsung, though IPO pricing, secondary share sales, and broader market reception introduce uncertainty across the closely matched leading brackets.
สรุปจาก AI ทดลองที่อ้างอิงข้อมูลจาก Polymarket ไม่ใช่คำแนะนำในการเทรดและไม่มีผลต่อการตัดสินตลาดนี้ · อัปเดตแล้ว


ระวังลิงก์ภายนอก
ระวังลิงก์ภายนอก
คำถามที่พบบ่อย